VideaHealth, a leading dental AI company, has recently received clearance from the U.S. Food and Drug Administration (FDA) for its revolutionary Videa Dental Assist software. This groundbreaking clearance expands the scope of AI detections to cover the most common dental diseases, marking a significant milestone in healthcare history. With over 30 AI algorithms incorporated, Videa Dental Assist is set to enhance patient care for the millions of patients supported by VideaAI each year.
The clearance applications of Videa Dental Assist are extensive, including the detection of periapical radiolucencies, calculus, and pediatric caries for children aged three and above. The software also offers a range of other AI models that enable subtle detections across all age groups, resulting in improved workflow and time-saving benefits. Notably, several of these detections are the first of their kind to receive approval from a regulatory agency worldwide, including the first pediatric radiology AI clearance in dentistry.
Dr. Tim Quirt, the Senior Vice President of Clinical Operations at Heartland Dental, expressed his excitement about the expanding capabilities and innovations of VideaHealth’s AI technology. Heartland Dental, one of the largest dental service organizations (DSOs), is proud to partner with VideaHealth and believes that their commitment to providers and their vision and mission are unparalleled. This latest development represents a significant advancement for AI in assisting dental professionals in delivering comprehensive care to their patients.
VideaAI has already gained widespread popularity among thousands of clinicians who rely on it as their dental AI tool of choice. By incorporating Videa Dental Assist into their daily practice, these clinicians are able to enhance patient care and achieve better clinical outcomes. Now, with the recent FDA clearance, VideaHealth becomes the first dental AI company to offer insights for virtually every dental disease state.
Headquartered in Boston, VideaHealth is at the forefront of dental AI technology. Their comprehensive suite of AI technology addresses a wide range of dental diseases and is utilized by practices of all sizes, from independent practices to large dental service organizations like Heartland Dental. Furthermore, VideaHealth has partnered with Henry Schein One, a respected technology company, to offer Dentrix Detect AI and Dentrix Ascend AI powered by VideaHealth to thousands of dental offices using Henry Schein One’s practice management software.
VideaHealth has received funding from prominent venture capital firms, including Spark Capital, Zetta Venture Partners, and Pillar VC. This financial support has enabled VideaHealth to continue developing cutting-edge AI solutions for the dental industry. For more information about VideaHealth and its products, dental professionals and interested parties can visit their website at https://www.videa.ai.